CMS advised Ypsomed on the closing of the sale of its pen needle and BGM businesses to MTD across 17 jurisdictions

Zurich, July 2024 | An international CMS team under the lead of Stefan Brunnschweiler and Florian Jung provided comprehensive advice to Ypsomed (SIX: YPSN) on all legal aspects regarding the completion of the sale of its pen needle and blood glucose monitoring systems (BGMs) businesses to Medical Technology and Devices S.p.A. (MTD) across 17 jurisdictions.

The sale of the pen needle and BGM businesses between Ypsomed and MTD was announced on 27 March 2024. The transaction is now legally completed after all conditions set out in the agreement have been fulfilled.

During a transition phase, Ypsomed will continue to produce pen needles as a contract manufacturer and provide services to enable a seamless transfer. The production facilities will be gradually relocated to the MTD sites by mid-2025. The space freed up will be used for a new toolmaking facility at the Solothurn site.

Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies, and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries, and distribution partners. Ypsomed has over 2,200 employees worldwide.

CMS Zurich

• Stefan Brunnschweiler, LL.M., Managing Partner, Head Corporate/M&A
• Florian Jung, LL.M., Senior Associate, Corporate/M&A
• Samuel Felix Gang, LL.M., Senior Associate, Corporate/M&A
• Anna Mast, Associate, Corporate/M&A
• Maximilian Hochreiter, Attorney Trainee, Corporate/M&A
• Alexander Salamon, Attorney Trainee, Corporate/M&A
• Marquard Christen, LL.M., MAS, Partner, Competition
• Sophia Rovelli, Attorney Trainee, Competition
• Nadine Anwander, Attorney Trainee, Competition
• Dr Matthias Kuert, LL.M., Partner, Capital Markets
• Mark Cagienard, LL.M. VAT, Partner, Tax
• Christian Gersbach, LL.M., Partner, Employment
• Dirk Spacek, LL.M., Partner, IT/IP

CMS Paris

• Alexandra Rohmert, Partner, Corporate/M&A
• Vincent Desbenoit, Associate, Corporate/M&A
• Caroline Froger-Michon, Partner, Employment
• Camille Baumgarten, Associate, Employment
• Aliénor Fevre, Counsel, Commercial
• Manon Fleury, Associate, Commercial
• Jean-Hugues de la Berge, Partner, Tax
• William Hamon, Partner, Tax

CMS Frankfurt

• Dr Heike Wagner, Partner, Corporate/M&A
• Dr Tobias Kilian, Of Counsel, Corporate/M&A
• Dr Reiner Thieme, Associate, Corporate/M&A

CMS Hamburg

• Dr Roland Wiring, Partner, IP

CMS Rome

• Pietro Cavasola, Managing Partner, Corporate/M&A
• Serena Carroli, Counsel, Corporate/M&A

CMS Stavanger

• Espen Debes, Partner, Corporate/M&A
• Preben Øvsthun-Sandvik, Corporate/M&A

CMS Oslo

• Johan Svedberg, Partner, Corporate/M&A

CMS Brussels

• Arnaud Van Oekel, Partner, Corporate/M&A
• Lola Verelst, Associate, Corporate/M&A

CMS Madrid

• Luis Miguel de Dios, Partner, Corporate/M&A
• Elena Alcazar, Counsel, Corporate/M&A

CMS Vienna

• Dieter Zandler, Partner, Competition
• Florian Mayer, Partner, Corporate/M&A

CMS Amsterdam

• Roman Tarlavski, Partner, Corporate/M&A
• Maarten Feenstra, Associate, Corporate/M&A

CMS London

• Tom Jameson, Partner, Corporate/M&A

CMS Prague

• Helen Rodwell, Partner, Corporate/M&A
• Monika Hospudkova, Associate, Corporate/M&A

CMS Stockholm

• Robert Kullgren, Partner, Corporate/M&A

MinterEllison (Australia)

• Con Boulougouris, Partner, Corporate/M&A
• Alex Beagley, Senior Associate, Corporate/M&A
• Will Crammond, Associate, Corporate/M&A

Moalem Weitemeyer (Denmark)

• Jakob Skafte-Pedersen, Partner, Corporate/M&A
• Michael Thai Hansen, Senior Associate, Corporate/M&A

HPP Attorney (Finland)

• Björn Nykvist, Partner, Corporate/M&A
• Andrew Cotton, Partner, Corporate/M&A
• Joska Rytkönen, Senior Associate, Corporate/M&A

Border Ladner Gervais (Canada)

• David Henry, Partner, Corporate/M&A

HSA Legal (India)

• Soumya De Mallik, Partner, Corporate/M&A
• Prithviraj Chauhan, Principal Associate, Corporate/M&A
• Meghna Rajesh, Associate, Corporate/M&A